Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014 (2014), Article ID 438528, 7 pages
http://dx.doi.org/10.1155/2014/438528
Research Article

Development and Optimization of Osmotically Controlled Asymmetric Membrane Capsules for Delivery of Solid Dispersion of Lycopene

School of Pharmaceutical Sciences, Shoolini University, Bajhol, Solan, Himachal Pradesh 173229, India

Received 29 August 2013; Accepted 19 December 2013; Published 29 January 2014

Academic Editors: J. Ali and T. Hatano

Copyright © 2014 Nitin Jain et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Marucci, G. Ragnarsson, and A. Axelsson, “Evaluation of osmotic effects on coated pellets using a mechanistic model,” International Journal of Pharmaceutics, vol. 336, no. 1, pp. 67–74, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Özdemir and J. Şahin, “Design of a controlled release osmotic pump system of ibuprofen,” International Journal of Pharmaceutics, vol. 158, no. 1, pp. 91–97, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Gupta, D. Bhandari, and A. Sharma, “Recent trends in oral drug delivery: a review,” Recent Patents on Drug Delivery and Formulation, vol. 3, no. 2, pp. 162–173, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Gupta, P. Basniwal, and G. Rathore, “Osmotically controlled oral drug delivery systems: a review,” International Journal of PharmTech Research, vol. 1, pp. 269–275, 2009. View at Google Scholar
  5. R. K. Verma, D. M. Krishna, and S. Garg, “Formulation aspects in the development of osmotically controlled oral drug delivery systems,” Journal of Controlled Release, vol. 79, no. 1–3, pp. 7–27, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. C.-Y. Wang, H.-O. Ho, L.-H. Lin, Y.-K. Lin, and M.-T. Sheu, “Asymmetric membrane capsules for delivery of poorly water-soluble drugs by osmotic effects,” International Journal of Pharmaceutics, vol. 297, no. 1-2, pp. 89–97, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Jain, R. Sareen, and K. L. Dhar, “In-situ solubility modulation for osmotic flow of cefadroxil through asymmetric membrane capsules,” RGUHS Journal of Pharmaceutical Sciences, vol. 2, no. 4, pp. 26–40, 2012. View at Google Scholar
  8. A. K. Philip and K. Pathak, “Wet process-induced phase-transited drug delivery system: a means for achieving osmotic, controlled, and level A IVIVC for poorly water-soluble drug,” Drug Development and Industrial Pharmacy, vol. 34, no. 7, pp. 735–743, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Agarwal and A. V. Rao, “Tomato lycopene and its role in human health and chronic diseases,” Canadian Medical Association Journal, vol. 163, no. 6, pp. 739–744, 2000. View at Google Scholar · View at Scopus
  10. W. Stahl and H. Sies, “Lycopene: a biologically important carotenoid for humans?” Archives of Biochemistry and Biophysics, vol. 336, no. 1, pp. 1–9, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. G. A. Rocha, C. S. Fávaro-Trindade, and C. R. F. Grosso, “Microencapsulation of lycopene by spray drying: characterization, stability and application of microcapsules,” Food and Bioproducts Processing, vol. 90, no. 1, pp. 37–42, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Vertzoni, T. Kartezini, C. Reppas, H. Archontaki, and G. Valsami, “Solubilization and quantification of lycopene in aqueous media in the form of cyclodextrin binary systems,” International Journal of Pharmaceutics, vol. 309, no. 1-2, pp. 115–122, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. A. K. Philip, K. Pathak, and P. Shakya, “Asymmetric membrane in membrane capsules: a means for achieving delayed and osmotic flow of cefadroxil,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 69, no. 2, pp. 658–666, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Karavas, E. Georgarakis, M. P. Sigalas, K. Avgoustakis, and D. Bikiaris, “Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 66, no. 3, pp. 334–347, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Sareen, N. Jain, and K. L. Dhar, “Development of colon specific microspheres of flurbiprofen for inflammatory bowel disease,” Current Drug Delivery, vol. 10, no. 5, pp. 564–571, 2013. View at Google Scholar
  16. United State Pharmacopoeia, United State Pharmacopoeial Convention, Rockville, Md, USA, 2004.